S.L.A. Pharma AG
- Country
- 🇨🇭Switzerland
- Ownership
- Private
- Established
- 1997-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.slapharma.com
Clinical Trials
11
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (11 trials with phase data)• Click on a phase to view related trials
EPA-FFA to Treat Hospitalised Patients With COVID-19 (SARS-CoV-2)
- Conditions
- SARS-CoV-2
- Interventions
- Drug: PlaceboDrug: Eicosapentaenoic acid gastro-resistant capsules
- First Posted Date
- 2020-04-06
- Last Posted Date
- 2021-12-03
- Lead Sponsor
- S.L.A. Pharma AG
- Target Recruit Count
- 284
- Registration Number
- NCT04335032
- Locations
- 🇪🇸
Hospital Universitario Vall d'Hebron, Barcelona, Spain
🇬🇧Hull, Cottingham, United Kingdom
🇬🇧UHCW, Coventry, United Kingdom
Metronidazole Ointment in Non-healing Pilonidal Sinus Wounds
- First Posted Date
- 2020-02-18
- Last Posted Date
- 2021-09-22
- Lead Sponsor
- S.L.A. Pharma AG
- Target Recruit Count
- 80
- Registration Number
- NCT04273997
- Locations
- 🇹🇷
Erzincan Binali Yıldırım University General Surgery Clinic, Erzincan, Turkey
🇹🇷Samsun Training and Research Hospital General Surgery Clinic, Samsun, Turkey
Effect of EPA-FFA on Polypectomy in Familial Adenomatous Polyposis
- Conditions
- Familial Adenomatous Polyposis
- Interventions
- Drug: Eicosapentaenoic acid free fatty acid (EPA-FFA)Drug: Placebo
- First Posted Date
- 2019-01-16
- Last Posted Date
- 2024-04-25
- Lead Sponsor
- S.L.A. Pharma AG
- Target Recruit Count
- 204
- Registration Number
- NCT03806426
- Locations
- 🇮🇹
University of Bologna and St.Orsola-Malpighi Hospital, Bologna, Italy
Diltiazem Hydrochloride Cream for Anal Fissure
- Conditions
- Chronic Anal Fissure
- Interventions
- First Posted Date
- 2010-10-08
- Last Posted Date
- 2014-07-17
- Lead Sponsor
- S.L.A. Pharma AG
- Target Recruit Count
- 465
- Registration Number
- NCT01217515
- Locations
- 🇧🇬
Dr Kantcho Kostadinov, Sevileva, Sevilieva, Bulgaria
🇧🇬Vth MHAT, Sofia, Bulgaria
🇧🇬MHAT Alexandrovska EAD, Sofia, Bulgaria
Naloxone SR Capsules in Patients With Opioid Induced Constipation
- Conditions
- Chronic PainOpioid Induced Constipation
- Interventions
- First Posted Date
- 2009-09-25
- Last Posted Date
- 2013-12-27
- Lead Sponsor
- S.L.A. Pharma AG
- Target Recruit Count
- 40
- Registration Number
- NCT00984334
- Locations
- 🇩🇪
Schmerzzentrum Berlin, Berlin, Germany
🇩🇪Schmerzzentrum Frankfurt, Frankfurt, Germany
🇩🇪Gemeinschaftspraxis Tamm-Albert-Schroter-Uhmann, Hannover, Germany
- Prev
- 1
- 2
- 3
- Next